Ashutosh A. Kulkarni

544 total citations
19 papers, 414 citations indexed

About

Ashutosh A. Kulkarni is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Ashutosh A. Kulkarni has authored 19 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Physiology. Recurrent topics in Ashutosh A. Kulkarni's work include Drug Transport and Resistance Mechanisms (7 papers), Amino Acid Enzymes and Metabolism (5 papers) and Adenosine and Purinergic Signaling (5 papers). Ashutosh A. Kulkarni is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Amino Acid Enzymes and Metabolism (5 papers) and Adenosine and Purinergic Signaling (5 papers). Ashutosh A. Kulkarni collaborates with scholars based in United States, Switzerland and United Kingdom. Ashutosh A. Kulkarni's co-authors include Vincent H.L. Lee, Ian S. Haworth, Daryl L. Davies, Mehran F. Moghaddam, Samantha J. Richardson, Tomomi Uchiyama, Jerold G. Woodward, R.L. Alkana, Bruce King and Hovhannes J. Gukasyan and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Ashutosh A. Kulkarni

19 papers receiving 407 citations

Peers

Countries citing papers authored by Ashutosh A. Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Ashutosh A. Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashutosh A. Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashutosh A. Kulkarni more than expected).

Fields of papers citing papers by Ashutosh A. Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashutosh A. Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashutosh A. Kulkarni. The network helps show where Ashutosh A. Kulkarni may publish in the future.

Co-authorship network of co-authors of Ashutosh A. Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Ashutosh A. Kulkarni. A scholar is included among the top collaborators of Ashutosh A. Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashutosh A. Kulkarni. Ashutosh A. Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	A nonhuman primate model of blue light-induced progressive outer retina degeneration showing brimonidine drug delivery system-mediated cyto- and neuroprotection 2021 ·Experimental Eye Research ·(unknown), Corine Ghosn, (unknown), (unknown), (unknown), Ashutosh A. Kulkarni, Lori‐Ann Christie, James A. Burke, Francisco J. López, (unknown)	8
2	Cyto-/neuro-protective effects of brimonidine drug delivery system (DDS) in a nonhuman primate progressive retinal degeneration model of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) 2019 ·(unknown), Corine Ghosn, (unknown), Ashutosh A. Kulkarni, Lori‐Ann Christie, (unknown), (unknown)	3
3	Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy 2019 ·Journal of Medicinal Chemistry ·Jennifer R. Riggs, (unknown), (unknown), Dale Robinson, Lida Tehrani, Mark A. Nagy, Kimberly E. Fultz, Rama Krishna Narla, Xiaohui Peng, Tam Tran, Ashutosh A. Kulkarni, Sogole Bahmanyar, Kevin R. Condroski, Barbra Pagarigan, Gustavo Fenalti, Laurie A. LeBrun, Katerina Leftheris, Dan Zhu, John F. Boylan	17
4	Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual Dysfunction 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Yong‐Xin Li, Jiaying Yang, (unknown), (unknown), Ashutosh A. Kulkarni, Ursula Stäubli, Alan C. Foster	9
5	Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability 2016 ·Drug Metabolism Letters ·Samantha J. Richardson, (unknown), Ashutosh A. Kulkarni, Mehran F. Moghaddam	97
6	A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs 2014 ·Drug Metabolism Letters ·Mehran F. Moghaddam, Yang Tang, Zhihong O’Brien, Samantha J. Richardson, (unknown), (unknown), Julius Apuy, Ashutosh A. Kulkarni	14
7	Proposing Advancement Criteria for Efficient Dmpk Triage of New Chemical Entities 2014 ·Future Medicinal Chemistry ·Ashutosh A. Kulkarni, (unknown), (unknown), (unknown), Andrew Calabrese, Tao Shi, Mehran F. Moghaddam	4
8	Use of Clonetics® Human Corneal Epithelial Cell Model for Evaluating Corneal Penetration and Hydrolysis of Ophthalmic Drug Candidates 2011 ·Ashutosh A. Kulkarni, William Chang, (unknown), Devin Welty	2
9	Mutagenesis and Cysteine Scanning of Transmembrane Domain 10 of the Human Dipeptide Transporter 2009 ·Pharmaceutical Research ·(unknown), Ian S. Haworth, Ashutosh A. Kulkarni, Michael B. Bolger, Daryl L. Davies	20
10	Ethanol Inhibits Functional Activity of the Human Intestinal Dipeptide Transporter hPepT1 Expressed in Xenopus Oocytes 2008 ·Alcoholism Clinical and Experimental Research ·(unknown), (unknown), Ashutosh A. Kulkarni, (unknown), Ian S. Haworth, Daryl L. Davies	1
11	Cysteine scanning of transmembrane domain three of the human dipeptide transporter: Implications for substrate transport 2007 ·Journal of drug targeting ·(unknown), Ashutosh A. Kulkarni, Daryl L. Davies, Vincent H.L. Lee, Ian S. Haworth	9
12	A Charge Pair Interaction Between Arg282 in Transmembrane Segment 7 and Asp341 in Transmembrane Segment 8 of hPepT1 2006 ·Pharmaceutical Research ·Ashutosh A. Kulkarni, Daryl L. Davies, (unknown), (unknown), Vincent H.L. Lee, Ian S. Haworth	19
13	Ethanol differentially affects ATP-gated P2X and P2X receptor subtypes expressed in oocytes 2005 ·Neuropharmacology ·Daryl L. Davies, (unknown), (unknown), Ashutosh A. Kulkarni, Jerold G. Woodward, Bruce King, R.L. Alkana	63
14	Nucleotide-Induced Restoration of Conjunctival Chloride and Fluid Secretion in Adenovirus Type 5-Infected Pigmented Rabbit Eyes 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Ashutosh A. Kulkarni, Melvin D. Trousdale, Douglas Stevenson, Hovhannes J. Gukasyan, (unknown), Kwang‐Jin Kim, Russell W. Read, Vincent H.L. Lee	12
15	Transmembrane segment 5 of the dipeptide transporter hPepT1 forms a part of the substrate translocation pathway 2003 ·Biochemical and Biophysical Research Communications ·Ashutosh A. Kulkarni, Ian S. Haworth, Vincent H.L. Lee	29
16	Analysis of Transmembrane Segment 7 of the Dipeptide Transporter hPepT1 by Cysteine-scanning Mutagenesis 2003 ·Journal of Biological Chemistry ·Ashutosh A. Kulkarni, Ian S. Haworth, Tomomi Uchiyama, Vincent H.L. Lee	31
17	Biophysical Evidence for His57 as a Proton-Binding Site in the Mammalian Intestinal Transporter hPepT1 2003 ·Pharmaceutical Research ·Tomomi Uchiyama, Ashutosh A. Kulkarni, Daryl L. Davies, Vincent H.L. Lee	35
18	Nucleoside and Nucleotide Stimulation of Fluid Secretion in the Pigmented Rabbit Conjunctiva 2002 ·Advances in experimental medicine and biology ·Vincent H.L. Lee, Ashutosh A. Kulkarni, (unknown)	6
19	Pharmacological modulation of fluid secretion in the pigmented rabbit conjunctiva 2000 ·Life Sciences ·(unknown), Ashutosh A. Kulkarni, Hovhannes J. Gukasyan, (unknown), Kwang‐Jin Kim, Vincent H.L. Lee	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact